Gene test can identify bits of cancer in blood
Posted 02-19-2010 at 01:59 PM by admin
Julie Steenhuysen
CHICAGO
Thu Feb 18, 2010 3:41pm EST
CHICAGO (Reuters) - A personalized blood test can tell whether a patient's cancer has spread or come back, offering a better way to see if treatments are working, U.S. researchers said on Thursday.
Having a test that can detect tumors in the blood could help doctors customize cancer treatments, offering more aggressive therapy to some patients while sparing others from unneeded chemotherapy or radiation.
"We're talking about what could be a management tool for a number of patients," said Dr Bert Vogelstein of Johns Hopkins University in Baltimore and the Howard Hughes Medical Institute, who worked on the study published in the journal Science Translational Medicine.
The gene-based test takes advantage of rapid advances in the technology to sequence whole genomes -- all of a person's genetic code -- once a very costly and time-consuming task.
"This is really personalized medicine. This is not something off the shelf," Vogelstein said in a telephone interview. "This is something that has to be designed for each individual patient."
For the study, the researchers took six sets of normal and cancerous tissue from four colorectal and two breast cancer patients, and mapped out the genetic code in each.
In the cancer samples, the team looked for areas in the genetic code where there were extra DNA copies, or where sections of chromosomes had fused together.
"There are about nine or so rearrangements on average in every sample," Dr Victor Velculescu of Johns Hopkins told reporters at the American Association for the Advancement of Science meeting in San Diego. "They are not present in the normal tissue."
Read the rest of the article here.
© Copyright 2010 Thomson Reuters
CHICAGO
Thu Feb 18, 2010 3:41pm EST
CHICAGO (Reuters) - A personalized blood test can tell whether a patient's cancer has spread or come back, offering a better way to see if treatments are working, U.S. researchers said on Thursday.
Having a test that can detect tumors in the blood could help doctors customize cancer treatments, offering more aggressive therapy to some patients while sparing others from unneeded chemotherapy or radiation.
"We're talking about what could be a management tool for a number of patients," said Dr Bert Vogelstein of Johns Hopkins University in Baltimore and the Howard Hughes Medical Institute, who worked on the study published in the journal Science Translational Medicine.
The gene-based test takes advantage of rapid advances in the technology to sequence whole genomes -- all of a person's genetic code -- once a very costly and time-consuming task.
"This is really personalized medicine. This is not something off the shelf," Vogelstein said in a telephone interview. "This is something that has to be designed for each individual patient."
For the study, the researchers took six sets of normal and cancerous tissue from four colorectal and two breast cancer patients, and mapped out the genetic code in each.
In the cancer samples, the team looked for areas in the genetic code where there were extra DNA copies, or where sections of chromosomes had fused together.
"There are about nine or so rearrangements on average in every sample," Dr Victor Velculescu of Johns Hopkins told reporters at the American Association for the Advancement of Science meeting in San Diego. "They are not present in the normal tissue."
Read the rest of the article here.
© Copyright 2010 Thomson Reuters
Total Comments 0
Comments
Recent Blog Entries by admin
- Approval to Market ABRAXANE for Metastatic Breast Cancer in New Zealand (07-29-2010)
- Potential Biomarkers of VELCADE Activity in Patients w/Relapsed Mantle Cell Lymphoma (07-29-2010)
- UT Health Science Center team finds adrenal cancer gene (07-29-2010)
- £50m boost to help cancer patients (07-29-2010)
- Generic Gemzar may appear soon (07-29-2010)






